Do you know the options available to prevent RSV in infants?
RSV Prevention Options for Infants
Infant Health Safety Call to Action
When hospital procurement decisions are focused on cost, patients pay the price.
The Indirect Impact of RSV
RSV, or respiratory syncytial virus, is a common, highly contagious seasonal virus that affects 97% of children by the age of 2. Yet despite RSV being common among young children, most parents know little about it.
Vaccines and Preventive Monoclonal Antibodies
Vaccines and preventive monoclonal antibodies are two different types of immunization. While they function differently, they both serve the same purpose: protecting people from serious illnesses and diseases.
The Burden of RSV: Impacting All Families
Respiratory syncytial virus places a heavy burden on infants, young children, their families and the health care system. Also known as RSV, this virus can impact children and families for months, years or even their entire lives.
And it doesn’t discriminate.
Monoclonal Antibodies Inclusion in the Vaccines for Children Program
By warding off diseases like influenza and pertussis, immunizations play a critical role in infant and early childhood health. Immunizations protect infants from life-threatening diseases, which can lead to both hospitalization and longterm complications.
Infant Health Matters: Innovation
Why is it important that medications and devices be developed specifically
for infants?
When it comes to medical innovation, not all patients are the same.
Infant Health Matters: RSV
A conversation with Donald M. Null, MD.
Q: What is RSV?
Respiratory syncytial virus is a seasonal virus that causes an infection of the lungs. RSV is the leading cause of hospitalization in children younger than one year old.